Growth Metrics

Invivyd (IVVD) Non-cash Items (2020 - 2025)

Invivyd posted quarterly Non-cash Items of $15.5 million for Q4 2025, up 22.24% on a QoQ basis from $12.7 million in Q3 2025.

Invivyd (IVVD) has 6 years of Non-cash Items data on file, last reported at $15.5 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items changed N/A year-over-year to $15.5 million; the trailing twelve-month figure through Dec 2025 stood at $15.5 million (changed N/A YoY), and the FY2025 full-year result was $15.5 million, up 120.22% from the prior year.
  • Non-cash Items for Q4 2025 stood at $15.5 million, up from $12.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $586.8 million in Q3 2021 and bottomed at $92500.0 in Q2 2021.
  • The 5-year median for Non-cash Items is $12.1 million (2024), against an average of $45.5 million.
  • Peak annual rise in Non-cash Items reached 4518.89% in 2022, while the deepest fall reached 98.95% in 2022.
  • A 5-year view of Non-cash Items shows it stood at $24.9 million in 2021, then slumped by 93.6% to $1.6 million in 2022, then jumped by 1452.38% to $24.7 million in 2023, then slumped by 53.5% to $11.5 million in 2024, then jumped by 34.92% to $15.5 million in 2025.
  • The last three Non-cash Items figures came in at $15.5 million (Q4 2025), $12.7 million (Q3 2025), and $14.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Invivyd 208.38 Mn -18.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 15.53 Mn
Dec 31, 2025 15.53 Mn
Sep 30, 2025 12.70 Mn
Sep 30, 2025 12.70 Mn
Jun 30, 2025 14.80 Mn
Jun 30, 2025 14.80 Mn
Mar 31, 2025 19.00 Mn
Mar 31, 2025 19.00 Mn
Sep 30, 2024 11.51 Mn
Sep 30, 2024 11.51 Mn
Jun 30, 2024 28.40 Mn
Jun 30, 2024 28.40 Mn
Mar 31, 2024 9.14 Mn
Mar 31, 2024 9.14 Mn
Dec 31, 2023 24.75 Mn
Dec 31, 2023 24.75 Mn
Sep 30, 2023 7.62 Mn
Sep 30, 2023 7.62 Mn
Jun 30, 2023 42.70 Mn
Jun 30, 2023 42.70 Mn
Mar 31, 2023 7.01 Mn
Mar 31, 2023 7.01 Mn
Dec 31, 2022 1.59 Mn
Dec 31, 2022 1.59 Mn
Sep 30, 2022 6.13 Mn
Sep 30, 2022 6.13 Mn
Jun 30, 2022 4.27 Mn
Jun 30, 2022 4.27 Mn
Mar 31, 2022 2.39 Mn
Mar 31, 2022 2.39 Mn
Dec 31, 2021 24.90 Mn
Dec 31, 2021 24.90 Mn
Sep 30, 2021 586.81 Mn
Sep 30, 2021 586.81 Mn
Jun 30, 2021 92,500.00
Jun 30, 2021 92,500.00
Dec 31, 2020 11.36 Mn
Dec 31, 2020 11.36 Mn